272024• Okai T, Chan CW, Kc A, Omondi P, Musyoka K, Kongere J, Kagaya W, Okomo G, Kanoi BN, Kido Y, Gitaka J, Kaneko A. Plasmodium falciparum with pfhrp2 and pfhrp3 gene deletions in asymptomatic malaria infections in the Lake Victoria region, Kenya. Trop Med Health. 2024 Dec 18; 52(1): 94.Kagaya W, Kaneko A. Previously undiagnosed disease “X” in the Democratic Republic of the Congo: malaria’s poten-tial role in the outbreak. Open Forum Infect Dis. Published April 18, 2025.• Kagaya W. Low-density Plasmodium falciparum infection: “Even a parasite will turn”. Parasitol Int. Published Febru-ary 20, 2025; 103052.• Ko YK, Kagaya W, Yoneoka D, Kongere J, Opiyo V, Oginga J, Omondi P, Musyoka KB, Chan CW, Kanoi BN, Gitaka J, Kaneko A. Where is the hard-to-reach popula-tion? Spatial analysis from a cross-sectional study on the access to bed net and malaria vaccine in the Lake Victoria Region, Kenya. Malar J. 2025 Feb 12; 24(1): 42.• Ko YK, Kagaya W, Omondi P, Musyoka KB, Okai T, Chan CW, Kongere J, Opiyo V, Oginga J, Mungai S, Kanoi BN, Kanamori M, Yoneoka D, Keitany KK, Songok E, Okomo GO, Minakawa N, Gitaka J, Kaneko A. Evaluation of the protective efficacy of OlysetPlus ceiling nets for reduction of malaria incidence in children in Homa Bay County, Kenya: a cluster-randomised controlled study protocol. BMJ Open. 2025 Jan 30.• Ko YK, Kagaya W, Chan CW, Kanamori M, Mbugua SM, Rotich AK, Kanoi BN, Ngara M, Gitaka J, Kaneko A. Unraveling the ‘community effects’ of interventions against malaria endemicity: a systematic scoping review. BMJ Public Health. 2024 Dec 4; 2(2): e001557.• Omondi P, Musyoka B, Okai T, Kongere J, Kagaya W, Chan CW, Ngara M, Kanoi BN, Kido Y, Gitaka J, Kaneko A. Non-random distribution of Plasmodium species infec-tions and associated clinical features in children in the Lake Victoria region, Kenya, 2012–2018. Trop Med Health. 2024 Aug 5; 52(1): 52.• Musyoka K, Chan CW, Gutiérrez Rico EM, Omondi P, Kijogi C, Okai T, Kongere J, Ngara M, Kagaya W, Kanoi BN, Hiratsuka M, Kido Y, Gitaka J, Kaneko A. Genetic variation present in the CYP3A4 gene in Ni-Vanuatu and Kenyan populations in malaria endemicity. Drug Metab Pharmacokinet. 2024 Jul 10; 57: 101029.• Sekine S, Chan CW, Kalkoa M, Yamar S, Iata H, Taleo G, Kc A, Kagaya W, Kido Y, Kaneko A. Tracing the origins of Plasmodium vivax resurgence after malaria elimination on Aneityum Island in Vanuatu. Commun Med. 2024 May 18; 4(1): 91.• Matsumoto T, Nagashima M, Kagaya W, Kongere J, Gitaka J, Kaneko A. Evaluation of a financial incentive interven-tion on malaria prevalence among the residents in Lake Victoria basin, Kenya: study protocol for a cluster-random-ized controlled trial. Trials. 2024 Mar 4; 25(1).• Miyazaki S, Chitama BYA, Kagaya W, Lucky AB, Zhu X, Yahata K, Morita M, Takashima E, Tsuboi T, Kaneko O. Plasmodium falciparum SURFIN4.1 forms an intermediate complex with PTEX components and Pf113 during export to the red blood cell. Parasitol Int. 2021 Aug 21; 83: 102358.□ Akira Kaneko, An integrated community-directed strategy for sustainable freedom from malaria in Kenya. TICAD9 side event, Yokohama, 21 August 2025□ Akira Kaneko, Insecticide-treated ceiling nets to combat partial artemisinin resistant malaria in tropical Africa. 21st International Congress for Tropical Medicine & Malaria, Kuching, Malaysia, 22 September 2024□ Wataru Kagaya, Olyset®Plus ceiling nets protect against malaria: Findings from a cluster randomized controlled trial of the effectiveness of Olyset®Plus ceiling net on reducing malaria prevalence and incidence on Mfangano Island, Lake Victoria basin, KenyaAmerican Society of Tropical Medicine and Hygiene 2024 Annual Meeting – 2024 年 11 月 15 日□ Wataru Kagaya, Insights from observational and interven-tional studies on malaria in the Lake Victoria Basin of Kenya第 93 回日本寄生虫学会大会 – 2024 年 3 月 10 日□ Tomoya Matsumoto, An economic intervention for anti-malarial behavior among the residents in Lake Victoria 2023• Osborne A, Phelan JE, Kaneko A, Kagaya W, Chan C, Ngara M, Kongere J, Kita K, Gitaka J, Campino S, Clark TG. Drug resistance profiling of asymptomatic and low-density Plasmodium falciparum malaria infections on Ngodhe Island, Kenya, using custom dual-indexing next-generation sequencing. Sci Rep. 2023 Jul 14; 13(1): 11416.• Kagaya W, Chan CW, Kongere J, Kanoi BN, Ngara M, Omondi P, Osborne A, Barbieri L, Kc A, Minakawa N, Gitaka J, Kaneko A. Evaluation of the protective efficacy of Olyset®Plus ceiling net on reducing malaria prevalence in children in Lake Victoria Basin, Kenya: study protocol for a cluster-randomized controlled trial. Trials. 2023 May 25; 24(1): 354.2022• Kagaya W, Takehara I, Kurihara K, Maina M, Chan CW, Okomo G, Kongere J, Gitaka J, Kaneko A. Potential appli-cation of the haematology analyser XN-31 prototype for field malaria surveillance in Kenya. Malar J. 2022 Sep 1; 21(1): 252.2021• Osborne A, Manko E, Takeda M, Kaneko A, Kagaya W, Chan C, Ngara M, Kongere J, Kita K, Campino S, Kaneko O, Gitaka J, Clark TG. Characterizing the genomic varia-tion and population dynamics of Plasmodium falciparum malaria parasites in and around Lake Victoria, Kenya. Sci Rep. 2021 Oct 6; 11(1): 19809.［国際学会，シンポジウム，招聘講演］日立感染症関連研究支援基金 研究成果報告書
元のページ ../index.html#29